8 months ago
CORT
AnalystsEdward NashEdward Nash's Stock Forecasts
AnalystsEdward Nash
Sectors:
Analyst Ranking
Bottom 12%
#4023 out of 4554 analysts
Average Return
-3.69%
Win Rate
35%17 out of 49
Risk vs Reward
Poor
Good
Edward Nash's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cardiol Therapeutics IncCRDL | +183.05% | $0.59 | $1.67 | 2023-05-18 - 2024-04-18 | Strong Buy |
Ventyx Biosciences IncVTYX | +148.19% | $13.57 | $33.68 | 2022-03-30 - 2023-03-30 | Strong Buy |
Verona Pharma PLCVRNA | +137.90% | $5.25 | $12.49 | 2021-11-11 - 2022-11-11 | Strong Buy |
Rani Therapeutics Holdings IncRANI | +99.67% | $3.03 | $6.05 | 2024-03-26 - 2024-04-18 | Strong Buy |
Amryt Pharma PLCAMYT | +92.60% | $7.57 | $14.58 | 2022-09-05 - 2023-01-10 | Strong Buy |
Edward Nash Analyst Color
Get additional color on Edward Nash's coverage of popular stocks
a year ago
CRDL
a year ago
AKRO
a year ago
AKRO
a year ago
VTYX
a year ago
TVTX
2 years ago
VTYX
2 years ago
VRNA
Edward Nash's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Inventiva SaIVA | 2 | Strong Buy | $20.00 | +479.71% | Maintains | 11 days ago |
Rani Therapeutics Holdings IncRANI | 1 | Strong Buy | $9.00 | +48.76% | Maintains | 23 days ago |
Madrigal Pharmaceuticals IncMDGL | 6 | Strong Buy | $377.00 | +69.62% | Maintains | a month ago |
Ventyx Biosciences IncVTYX | 5 | Strong Buy | $15.00 | +244.83% | Maintains | a month ago |
Morphic Holding IncMORF | 2 | Strong Buy | $66.00 | +139.91% | Maintains | a month ago |
Corcept Therapeutics IncCORT | 3 | Strong Buy | $38.00 | +67.70% | Maintains | 4 months ago |
Intercept Pharmaceuticals IncICPT | 7 | Hold | $19.00 | 0.00% | Downgrades | 7 months ago |
Verona Pharma PLCVRNA | 3 | Strong Buy | $35.00 | +117.39% | Reiterates | 8 months ago |
Travere Therapeutics IncTVTX | 5 | Strong Buy | $35.00 | +503.45% | Maintains | 9 months ago |
Theratechnologies IncTHTX | 4 | Hold | $8.00 | +510.69% | Assumes | 10 months ago |
Dice Therapeutics IncDICE | 3 | Hold | $48.00 | +0.95% | Downgrades | 10 months ago |
Cardiol Therapeutics IncCRDL | 2 | Strong Buy | $6.00 | +259.28% | Maintains | a year ago |
Pliant Therapeutics IncPLRX | 1 | Strong Buy | $48.00 | +293.77% | Initiates Coverage On | a year ago |
Akero Therapeutics IncAKRO | 3 | Strong Buy | $59.00 | +187.66% | Maintains | a year ago |
Oramed Pharmaceuticals IncORMP | 2 | Hold | $2.00 | -9.09% | Maintains | a year ago |
Amryt Pharma PLCAMYT | 2 | Hold | $17.00 | N/A | Downgrades | a year ago |
Galmed Pharmaceuticals LtdGLMD | 2 | Hold | $15.00 | N/A | Downgrades | 2 years ago |
Chemocentryx IncCCXI | 2 | Hold | $52.00 | N/A | Downgrades | 2 years ago |
Rezolute IncRZLT | 1 | Strong Buy | $17.00 | N/A | Assumes | 2 years ago |
Obseva SaOBSVF | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | 2 years ago |
Metacrine IncMTCR | 1 | Hold | $1.00 | N/A | Downgrades | 2 years ago |
Adverum Biotechnologies IncADVM | 3 | Hold | $80.00 | N/A | Maintains | 5 years ago |
Ultragenyx Pharmaceutical IncRARE | 2 | Strong Buy | $54.00 | N/A | Maintains | 5 years ago |
Entasis Therapeutics Holdings IncETTX | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 5 years ago |
Uniqure NvQURE | 1 | Strong Buy | $48.00 | N/A | Initiates Coverage On | 6 years ago |
Abeona Therapeutics IncABEO | 1 | Strong Buy | $650.00 | N/A | Initiates Coverage On | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.